幽门螺杆菌
癌症
医学
细菌
抗生素耐药性
内科学
生物
抗生素
重症监护医学
微生物学
免疫学
遗传学
作者
Majid Taati Moghadam,Zahra Chegini,Amin Norouzi,Amin Sadeghi Dousari,Aref Shariati
出处
期刊:Current Pharmaceutical Biotechnology
[Bentham Science]
日期:2021-06-01
卷期号:22 (7): 945-959
被引量:13
标识
DOI:10.2174/1389201021666200807110849
摘要
Background: Helicobacter pylori causes dangerous and deadly diseases such as gastric cancer and duodenal ulcers. Eradication and treatment of this bacterium are very important due to the deadly diseases caused by H. pylori and the high cost of treatment for countries. Results: Many efforts have been made to control and eradicate this bacterium over the years, but no success has been achieved since its eradication is a complex process affected by the bacterial properties and host factors. Previous studies have shown that various factors are involved in the failure to eradicate H. pylori, such as new genotypes of the bacterium with higher pathogenicity, inappropriate patient cooperation, mutations, biofilm formation and dormant forms that cause antibiotic resistance, acidic stomach pH, high bacterial load, smoking, immunosuppressive features and intracellular occurrence of H. pylori. On the other hand, recent studies reported that the use of probiotics, nanoparticles, antimicrobial peptides, natural product and vaccines can be helpful in the treatment and eradication of H. pylori infections. Methods: Thus, we present a complete list of the most important causes of failure in the treatment and eradication of H. pylori, and address new therapeutic methods that may be effective in controlling this bacterium in the future. Conclusion: Eradication of H. pylori is crucial for the treatment of important diseases such as gastric cancer. Therefore, it seems that identifying the failure causes of treating this bacterium can be helpful in controlling the infections. Besides, further studies on new therapeutic strategies may help eradicate H. pylori in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI